
    
      This is a special drug use surveillance on long-term use of newly co-administered
      pioglitazone tablets (Actos Tablets) as part of routine medical care in patients with type 2
      diabetes mellitus who have poorly controlled blood glucose when using an insulin product in
      addition to diet therapy and exercise therapy; this survey is designed to determine the
      safety and efficacy of long-term use of pioglitazone tablets (Actos Tablets) in the routine
      clinical setting in combination with an insulin product (the planned sample size, 1000.) The
      usual adult dosage is 15 mg of pioglitazone administered orally once daily before or after
      breakfast. Dose adjustment will be made according to gender, age, and symptoms with an upper
      limit of 30 mg.
    
  